MAR 24, 2020 4:54 PM PDT

Certain Drugs May Raise the Risk of a Severe COVID-19 Infection

WRITTEN BY: Carmen Leitch

A researcher at the Louisiana State University (LSU) Health New Orleans School of Public Health has suggested that some medications may make the coronavirus SARS-CoV-2 more likely to attach to receptors in the trachea, bronchi, and bronchioles called angiotensin-converting enzyme 2 (ACE2) receptors. The coronaviruses is known to bind to these ACE2 receptors, which allows the virus to get into lung cells. If a patient is on certain drugs, it may encourage the infection, leading to pneumonia and respiratory failure after ten to fourteen days, which can be fatal in some people. However, it is still vital that people taking these medications continue to take them; this news should simply serve as a note that these medicated individuals should take every precaution (like self-isolation and proper handwashing) to prevent the virus.

SARS-CoV-2 / Credit: Centers for Disease Control and Prevention

The hypothesis, proposed by James Diaz, MD, MHA, MPH & TM, Dr PH, Professor, and Head of Environmental Health Sciences, may help explain why some COVID-19 patients have serious respiratory complications. It has been reported in the Journal of Travel Medicine.

"Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are highly recommended medications for patients with cardiovascular diseases including heart attacks, high blood pressure, diabetes, and chronic kidney disease to name a few," explained Dr. Diaz. "Many of those who develop these diseases are older adults. They are prescribed these medications and take them every day."

In experimental models, intravenous infusions of ACEIs leads to an increase in the level of ACE2 receptors in the cardiopulmonary circulation.

"Since patients treated with ACEIs and ARBS will have increased numbers of ACE2 receptors in their lungs for coronavirus S proteins to bind to, they may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections," noted Diaz.

There is some data to support this hypothesis, Diaz added. In 1,099 confirmed SARS-CoV-2 infections in China, the outcomes for patients that had hypertension, diabetes, coronary artery disease, or chronic renal disease, were worse.

Children may be gaining some protection from infection through this mechanism, because they carry lower levels of ACE2 inhibitors in their lower respiratory tracts, thereby not attracting as many viral particles, Diaz suggested. They may also have higher levels of antibodies generated by coronaviruses that cause colds, he continued.

Future studies will be needed to study this connection, but until then it may be best for people on those medications to be extra careful.

"Patients treated with ACEIs and ARBs for cardiovascular diseases should not stop taking their medicine, but should avoid crowds, mass events, ocean cruises, prolonged air travel, and all persons with respiratory illnesses during the current COVID-19 outbreak in order to reduce their risks of infection."

Sources: AAAS/Eurekalert! via Louisiana State University Health Sciences Center, Journal of Travel Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Using Stem Cells to Treat Chronic Pain
Scientists have used a mouse model to show that human stem cells could be used to engineer neurons that stop pain....
JAN 27, 2020
Microbiology
JAN 27, 2020
Microbes in Household Dust May Be Spreading Antibiotic Resistance
Bacteria live in household dust, and sometimes a few of those microbes are pathogenic or carry genes that confer resistance to antibiotics....
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, multiply, and spread. Identifying...
FEB 13, 2020
Cell & Molecular Biology
FEB 13, 2020
Study of Early-Onset Parkinson's Reveals Potential Therapeutic
Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising....
FEB 24, 2020
Cell & Molecular Biology
FEB 24, 2020
How Brain Cells Can Protect Muscles
Protein buildup is not only a problem for the brain, it can also impair muscles....
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job done. The job? Specifically target ce...
Loading Comments...